Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
25.08. | Valneva's Chikungunya Shot Suspended by FDA | ||
22.08. | Nusano Cuts Ribbon on Radioisotope Production Facility | ||
22.08. | Thermo Fisher Scientific Opens Manufacturing Facility in Mebane, NC | ||
22.08. | Johnson & Johnson to Invest $2B in North Carolina Manufacturing Facility | ||
22.08. | Bio-Thera, STADA Extend Biosimilars Alliance to Tocilizumab | ||
22.08. | AAHI Taps Quratis as Preferred Vaccine Manufacturer | ||
21.08. | Andelyn Biosciences & Amplo Biotech Partner on AAV Gene Therapy Manufacturing | ||
21.08. | Parexel Taps Jim Anthony as CCO and President, Parexel Biotech | ||
21.08. | Piramal, NewAmsterdam Pharma Open Dedicated OSD Form Suite | ||
21.08. | Advanz Pharma & Alvotech Gain European Approval for Mynzepli | ||
21.08. | Kite to Acquire Interius BioTherapeutics for $350M | ||
20.08. | Schreiner MediPharm & Bluesight Introduce RFID-Based Inventory Solution | ||
20.08. | Altasciences Earns EcoVadis Gold Medal | ||
20.08. | LSPedia's Track-and-Trace Solution Expands Globally with Spring Bio Partnership | ||
20.08. | Jazz Pharmaceuticals, Saniona Enter Exclusive Agreement | ||
20.08. | Nucleus RadioPharma Appoints Dr. Stephen Hahn as CEO | ||
19.08. | FDA Approves Novo Nordisk's Wegovy for MASH | ||
19.08. | BioMed X, Novo Nordisk Launch Oral Peptide Drug Delivery Collaboration | ||
19.08. | FDA Issues Complete Response Letter for PTC's Vatiquinone NDA | ||
18.08. | IQVIA, Veeva Announce Long-term Clinical & Commercial Partnerships | ||
18.08. | Upperton Pharma Solutions Awarded VaxHub Sustainable Grant | ||
18.08. | Anocca Raises $46M to Advance Clinical Trial Targeting Pancreatic Cancer | ||
18.08. | Izalontamab Brengitecan Granted Breakthrough Therapy Designation | ||
18.08. | Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation | ||
15.08. | FDA Fully Approves Precigen's Papzimeos |